Mark Erlander, Chief Executive Officer at Cardiff Oncology, Inc. (CRDF), bought 965 shares at $10.34 ($10K) on 2021-03-23, disclosed to the SEC on 2021-03-23.
Open-market purchase of $10k CRDF by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| TROV | BUY | 2016-12-15 | $10K | — | Filing → |